Legal Representation
Attorney
ROBERT P. PARKER
USPTO Deadlines
Next Deadline
1475 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20240102)
Due Date
January 02, 2030
Grace Period Ends
July 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 2, 2024 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 2, 2024 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| May 9, 2023 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| May 9, 2023 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
| May 8, 2023 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| May 8, 2023 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| May 8, 2023 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| May 8, 2023 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| May 8, 2023 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| May 5, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 6, 2023 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| May 6, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 5, 2023 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Nov 8, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 8, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 8, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 27, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 26, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 26, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 8, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 16, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 16, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 16, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 18, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 18, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development and medical device and diagnostic research and development
First Use Anywhere:
Feb 22, 2022
First Use in Commerce:
Feb 22, 2022
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CONSULTING"